{ "market" : {"NAME" : "", "ID" : "us", "TZ" : "", "TZOFFSET" : "-14400", "open" : "", "close" : "", "flags" : ""} ,"STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com" ,"arrowAsChangeSign" : false ,"throttleInterval": "1000","localize":"0" ,"region": "US","lang" : "en-US","mu":"1" ,"up_arrow_icon" :"http://l.yimg.com/a/i/us/fi/03rd/up_g.gif" , "down_arrow_icon":"http://l.yimg.com/a/i/us/fi/03rd/down_r.gif" ,"up_color" :"green" , "down_color":"red","pass_market_id" : "0","market_status_yrb" :"YFT_MARKET_WILL_OPEN"}
Medipattern's Visualize:Vascular(TM) to be made available in the North East United States through Ultrasound Solutions Corporation

Press Release Source: The Medipattern Corporation On Tuesday June 14, 2011, 6:30 am EDT

TORONTO, ONTARIO--(Marketwire - June 14, 2011) -

Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI - News), a pioneer in the development of medical imaging software solutions that help medical practitioners in better understanding lesions and critical anatomy, is pleased to announce that Ultrasound Solutions Corporation (USC) will market and sell Medipattern's Visualize:Vascular(TM) product in the North East United States. USC is an ultrasound equipment sales and service organization with a sales and distribution network that stretches from Virginia, Ohio, and Michigan through to Maine. USC plans to promote Medipattern's vascular products to new clients as well as its current client base consisting of more than 1,000 accounts including over 650 dedicated cardiovascular practices which are a primary target market for Visualize:Vascular.

Visualize:Vascular performs 3D rendering of the lumen, the inside of the vessel where blood flows, showing the active pathway to the brain in carotid arteries. The maximum and minimum points in the lumen are automatically found and measured using this visualization tool. 3D rendering of the lumen from ultrasound imaging provides relevant additional information to quickly and conveniently assist in assessing the health of a patient's carotid artery in a physician's office environment. In general, 3D rendering is a common procedure with its own recognized Current Procedural Terminology (CPT) code.

The product will be offered based on a per-use model. Limited licensed keys will be loaded in standard increments of 15 and 100 uses. Ultrasound Solutions will provide installation for its customers while Medipattern will maintain license updates through a web licensing system. "The initial feedback from our customers indicates that they are all quite enthusiastic about the Visualize:Vascular product," comments Nat Romeo, President and CEO of USC. "Ultrasound is commonly used in cardiovascular offices. Medipattern enables the physicians in each office to see the luminal physiology in 3D which vastly increases understanding. Our customers see that Medipattern has the ability to improve patient care."

"USC is an outstanding service provider, ensuring that their clients are up and running in peak performance. Their excellence in customer service provides them with a very loyal customer base that value USC's input when exploring applications to improve their practice. The USC customer base has been extremely receptive to the introduction of Visualize:Vascular. This product will be very meaningful to their general radiologists, vascular surgeons and cardiologists. We look forward to working with the USC team," commented Jeff Collins, President and CEO of The Medipattern Corporation.

Visualize:Vascular received FDA 510(k) clearance in February, 2011. The product has been in limited clinical use since that time and is now ready for sale with initial shipments expected in June. The company plans a controlled product launch rolling out on a region by region basis beginning this summer.

2011 Upcoming Events:

-- Society of Vascular Surgery (SVS) Annual Meeting, Chicago June 16-18

-- Society of Vascular Ultrasound (SVU) Annual Meeting, Chicago June 16-18

About The Medipattern Corporation:

Medipattern® is a pioneer in the development of imaging software solutions that help medical practitioners to better understand lesions and critical anatomy. Medipattern uses its Cadenza(TM) technology to process images, finding the salient region of interest and presenting them in 2D and 3D formats that enhance the reader's perception. For more information, please visit the Company's website: www.medipattern.com.

About Ultrasound Solutions Corporation:

Ultrasound Solutions Corp is an independent ultrasound repair, service and equipment sales company, owned and operated by professionals with over 30 years of experience in the ultrasound industry. Our services include equipment sales, parts sales, preventive maintenance, customized service contracts, emergency repairs, and equipment training programs. Our mission is to provide you with fast response times and cost effective ultrasound repairs to improve your imaging equipment uptime and keeping your patients happy, as well as offer high quality, pre-owned equipment with new equipment warranties. For more information, please visit USC's website: www.uscultrasound.com.

B-CAD® and Medipattern® are a registered mark of The Medipattern Corporation.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential," and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Jeff Collins

The Medipattern Corporation

CEO

(416) 744-0009 ext. 224

www.medipattern.com

Kevin O'Connor

Spinnaker Capital Markets Inc.

(416) 962-3300 ext. 226